How Systemic Therapy is Combating Advanced CSCC

How Systemic Therapy is Combating Advanced CSCC

Episodes

Specialty:

All

Year:

All

EP. 1: Historical Treatment Approaches for CSCC

October 24th 2019

EP. 2: Unresectable CSCC: An Improved Standard of Care

October 24th 2019

EP. 3: Impact of Data From the EMPOWER-CSCC-1 Study

October 24th 2019

EP. 4: Unresectable CSCC: Experience With Checkpoint Inhibition

October 24th 2019

EP. 5: Unresectable CSCC: Checkpoint Inhibitor Dosing & Management

October 24th 2019

EP. 6: Next Steps for Checkpoint Inhibitors in CSCC

October 24th 2019

EP. 7: Future Management of Cutaneous Squamous Cell Carcinoma

October 24th 2019

Trending on OncLive

ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma

The OncFive: Top Oncology Articles for the Week of 8/16

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC

Darlifarnib Plus Cabozantinib Displays Early Signals of Safety and Efficacy in RCC